Tebideutorexant[1] (developmental code names JNJ-61393215, JNJ-3215) is an orexin antagonist medication which is under development for the treatment of depression and anxiety disorders.

[2][3][4][5] It is an orally active compound and acts as a selective antagonist of the orexin OX1 receptor (1-SORA).

[3][4][5] Preliminary clinical findings suggest that tebideutorexant may have anti-panic effects in humans.

[2] The drug was originated and developed by Janssen Pharmaceuticals.

This drug article relating to the nervous system is a stub.